FDA to warn on potential Johnson & Johnson COVID-19 vaccine link to rare disorder, report says
Fox News
The Food and Drug Administration is reportedly expected to administer a new warning on the Johnson & Johnson COVID-19 vaccine and a possible link to Guillain-Barré, a rare autoimmune nerve disorder.
Johnson & Johnson, the FDA and the Centers for Disease Control and Prevention (CDC) did not immediately respond to Fox News’ requests for comment. According to the CDC, Guillain-Barré occurs when a person’s immune system damages the nerves, spurring muscle weakness and in some cases, paralysis. Symptoms can last for several weeks to years, and while most will go on to fully recover, some are left with permanent nerve damage. Triggers for the rare syndrome include recent respiratory illness or diarrhea weeks before symptoms, or viral infections like the flu and Zika virus.More Related News